Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, Esther W. de Bekker‐Grob, Andrew Briggs, Chris Carswell, Lisa Caulley, Nathorn Chaiyakunapruk, Dan Greenberg, Elizabeth Loder, Josephine Mauskopf, C. Daniel Mullins, Stavros Petrou, Raoh‐Fang Pwu, Sophie Staniszewska, Ivett Jakab, Emma Kinloch, Eric Low, Jean Mossman, Declan Noone, Phil Posner, Jo Watson, Wendy Babidge, Lyn Beamesderfer, Dior Beerens, Tillie Cryer, Ana Donnelly, Manuel Espinoza, Wolfgang Greiner, Laura E. Happe, Mickaël Hiligsmann, Christine Lainé, Lin Lee, Ken Lee, Natalie Pafitis, Julia Robinson, Kenneth M. Steín, Eva Szunyogová, Wim Weber, Timothy Wrightson, Brian J. Zikmund‐Fisher, Marie-Claude Aubin, Marc L. Berger, John Campbell, Doug Coyle, Matthew S. Dyer, Richard Edlin, Rita Faria, Verónica Murillo Gallegos, Alastair Gray, Scott D. Grosse, Jason R. Guertin, Dyfrig Hughes, Florencia Hutter, Denny John, Hanin Farhana Kamaruzaman, David Kim, Murray Krahn, Dan Moldaver, Ku Rahim Ku AbdNurhasni, Daniela Vianna Pachito, Michael Paulden, Clinton J. Pecenka, Andrés Pichón-Rivière, John Powell, Lisa A. Prosser, Dean A. Regier, Anna Ringborg, Rossana Rivas, Chris Sampson, Marisa Santos, Paul Scuffham, Mark Sculpher, Katia Senna, Eldon Spackman, Lotte Steuten, David Tamblyn, Kilgore Trout, Dick Willke, Torbjørn Wisløff, Tadesse Melaku Abegaz, A. Kostyuk, Kelly Lenahan, Nan Luo, Joshua Soboil, R. White, David Moher, Elizabeth MolsenThe European Journal of Health Economics2022 · DOI
The CHEERS 2022 statement provides an updated, 28-item checklist and guidance for reporting health economic evaluations. This revision aims to improve the clarity, interpretability, and usefulness of these studies for decision-making by reflecting new methods, broader applicability, and the increased importance of stakeholder involvement.
What Problem Does This Paper Address?
Health economic evaluations are crucial for informing decisions about healthcare interventions by comparing their costs and consequences. However, a significant challenge has been the lack of standardization and transparency in how these evaluations are reported. This makes it difficult for readers, reviewers, and policymakers to understand, interpret, and utilize the findings. The original CHEERS statement, published in 2013, aimed to address this, but the field has evolved, necessitating an update to the reporting standards.
Methods
The development of the CHEERS 2022 statement involved a rigorous revision process. This included:
Informal Review: An assessment of reporting guidelines published since the original CHEERS statement.
Task Force and PPIE Involvement: A dedicated task force was convened, and a group of patient and public involvement and engagement (PPIE) contributors reviewed the draft checklist, suggesting language improvements and additional items.
Modified Delphi Panel: Experts in economic evaluation, journal editing, decision-making, health technology assessment, and commercial life sciences participated in a modified Delphi process to refine the checklist.
Web-based Survey: Panellists and PPIE contributors provided feedback via a web-based survey.
Finalization: Task Force members discussed feedback from each round, ultimately finalizing the checklist.
The guiding principle throughout was to ensure that economic evaluations made publicly available are understandable, interpretable, and replicable.
Datasets
Not discussed in the paper. This paper focuses on reporting standards rather than empirical research using specific datasets.
Key Insights and Ideas
Broader Applicability: The CHEERS 2022 statement is designed to be more inclusive, covering all types of health economic evaluations (e.g., cost-benefit analyses, equity considerations) and a wider range of interventions (beyond just healthcare, including public health, education, and social care).
Stakeholder Inclusion: A significant update is the explicit inclusion of items related to the involvement of patients, service recipients, the general public, and other stakeholders in the research process. This acknowledges the growing importance of diverse perspectives in health research.
Addressing Misuse: The authors acknowledge that the original CHEERS checklist was sometimes misused as a tool to assess the quality of methods rather than the quality of reporting. The updated guidance clarifies its intended purpose.
Transparency and Reproducibility: The core aim remains to enhance transparency and facilitate the reproducibility of health economic evaluations, which is vital for informed decision-making.
New Item for Health Economic Analysis Plans: The updated checklist includes an item on reporting the existence and availability of a health economic analysis plan, promoting a more structured and transparent approach to study design.
Key Results
The primary "result" of this paper is the presentation of the CHEERS 2022 statement, which comprises a 28-item checklist. This checklist is detailed in Table 1 of the paper and covers seven main categories: Title, Abstract, Introduction, Methods, Results, Discussion, and Other Relevant Information. The paper provides a brief overview of the checklist and its recommendations, with a more comprehensive Explanation and Elaboration report available separately.
Limitations and Future Work
Space Constraints: The authors acknowledge that the comprehensive information required for adequate reporting may exceed the space limitations of many journal articles. They suggest that journals and authors should utilize online and supplementary appendices to provide this detail.
Scope Exclusion: Budget impact analyses and constrained optimization studies are explicitly excluded from the scope of CHEERS guidance, as they require specialized reporting.
Potential for Misuse: Despite efforts to clarify its purpose, the authors note that reporting guidelines are often used inappropriately, and the rate of inappropriate use of CHEERS has increased since its initial publication. They are actively working on strategies to increase appropriate use.
Ongoing Evaluation: A formal study is underway to evaluate the impact of the original CHEERS statement on reporting quality, with results expected in 2022.
Future Development: The authors encourage the development of CHEERS extensions for specific areas and welcome translations of the CHEERS 2022 statement into other languages. They also invite feedback for continuous improvement.
Summary updated
Abstract
Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc.). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.
BibTeX
@article{husereau2022consolidated,
author = {Don Husereau and Michael Drummond and Federico Augustovski and Esther W. de Bekker‐Grob and Andrew Briggs and Chris Carswell and Lisa Caulley and Nathorn Chaiyakunapruk and Dan Greenberg and Elizabeth Loder and Josephine Mauskopf and C. Daniel Mullins and Stavros Petrou and Raoh‐Fang Pwu and Sophie Staniszewska and Ivett Jakab and Emma Kinloch and Eric Low and Jean Mossman and Declan Noone and Phil Posner and Jo Watson and Wendy Babidge and Lyn Beamesderfer and Dior Beerens and Chris Carswell and Tillie Cryer and Ana Donnelly and Manuel Espinoza and Dan Greenberg and Wolfgang Greiner and Laura E. Happe and Mickaël Hiligsmann and Christine Lainé and Lin Lee and Ken Lee and Elizabeth Loder and Natalie Pafitis and Julia Robinson and Kenneth M. Steín and Eva Szunyogová and Wim Weber and Timothy Wrightson and Brian J. Zikmund‐Fisher and Marie-Claude Aubin and Marc L. Berger and John Campbell and Doug Coyle and Matthew S. Dyer and Richard Edlin and Rita Faria and Verónica Murillo Gallegos and Alastair Gray and Scott D. Grosse and Jason R. Guertin and Dyfrig Hughes and Florencia Hutter and Denny John and Hanin Farhana Kamaruzaman and David Kim and Murray Krahn and Dan Moldaver and Ku Rahim Ku AbdNurhasni and Daniela Vianna Pachito and Michael Paulden and Clinton J. Pecenka and Andrés Pichón-Rivière and John Powell and Lisa A. Prosser and Dean A. Regier and Anna Ringborg and Rossana Rivas and Chris Sampson and Marisa Santos and Paul Scuffham and Mark Sculpher and Katia Senna and Eldon Spackman and Lotte Steuten and David Tamblyn and Kilgore Trout and Dick Willke and Torbjørn Wisløff and Tadesse Melaku Abegaz and A. Kostyuk and Kelly Lenahan and Nan Luo and Joshua Soboil and R. White and David Moher and Elizabeth Molsen},
title = {{Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations}},
journal = {The European Journal of Health Economics},
year = {2022},
doi = {10.1007/s10198-021-01426-6},
}